Copyright
©2016 Baishideng Publishing Group Co.
World J Nephrol. Mar 6, 2016; 5(2): 204-212
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.204
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.204
Table 1 Characteristics of peritoneal dialysis patients
Characteristics of patients | |
Sex (male/female) | 122/96 (56% male) |
Etiology (non-DM/DM) | 179/36 (17% diabetes) |
Age (yr) | 56 (20, 46, 64, 84) |
PD duration (mo) | 40 (1, 15, 63, 206) |
Peritonitis episode (times) | 0 (0, 0, 1, 9) |
D/P Cr | 0.65 (0.38, 0.59, 0.71, 0.88) |
D/D 0 glucose | 0.40 (0.21, 0.34, 0.44, 0.59) |
Table 2 Biomarker levels in the peritoneal effluent
Biomarker | Level in the peritoneal effluent |
Matrix metalloproteinase-2 (ng/mL) | 159 (14, 107, 220, 681) |
Interleukin-6 (pg/mL) | 14.6 (1.5, 7.6, 29.6, 253.5) |
Hyaluronan (ng/mL) | 109 (5.1, 53, 204, 889) |
Cancer antigen 125 (U/mL) | 6.7 (0.7, 4.0, 12.1, 91.8) |
Table 3 Correlation between patient characteristics and effluent biomarker levels
Biomarker levels in the peritoneal effluents | ||||
MMP-2 | IL-6 | Hyaluronan | CA125 | |
Sex (male/female) | P = 0.92 | P = 0.54 | P = 0.48 | P < 0.05 |
Etiology (non-DM/DM) | P = 0.18 | P = 1.00 | P = 0.56 | P < 0.05 |
Age (yr) | ρ = 0.076 | ρ = 0.12 | ρ = 0.046 | ρ = -0.096 |
P = 0.27 | P = 0.092 | P = 0.50 | P = 0.16 | |
PD duration (mo) | ρ = 0.050 | ρ = 0.15 | ρ = 0.25 | ρ = -0.062 |
P = 0.47 | P < 0.05 | P < 0.01 | P = 0.93 | |
Peritonitis episode (times) | ρ = 0.17 | ρ = 0.25 | ρ = 0.092 | ρ = -0.012 |
P < 0.05 | P < 0.001 | P = 0.20 | P = 0.86 |
Table 4 Correlation between effluent biomarker levels and the results of peritoneal equilibration test
D/P Cr | D/D0 glucose | MMP-2 | IL-6 | Hyaluronan | CA125 | |
D/P Cr | ρ = 1 | ρ = -0.86 | ρ = 0.74 | ρ = 0.46 | ρ = 0.27 | ρ = 0.13 |
P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P = 0.051 | ||
D/D0 Glucose | ρ = 1 | ρ = -0.65 | ρ = -0.28 | ρ = -0.22 | ρ = -0.094 | |
P < 0.001 | P < 0.001 | P < 0.005 | P = 0.19 | |||
MMP-2 | ρ = 1 | ρ = 0.54 | ρ = 0.40 | ρ = 0.1 | ||
P < 0.001 | P < 0.001 | P < 0.05 | ||||
IL-6 | ρ = 1 | ρ = 0.45 | ρ = 0.26 | |||
P < 0.001 | P < 0.001 | |||||
Hyaluronan | ρ = 1 | ρ = 0.18 | ||||
P < 0.01 | ||||||
CA125 | ρ = 1 |
Table 5 Test performance of effluent biomarkers cut-off levels to distinguish the high category of peritoneal equilibration test
Biomarkers | Cut-off level | Sensitivity (95%CI) | Specificity (95%CI) | AUC |
MMP-2- | 214 ng/mL | 0.95 (0.86 to 1.00) | 0.79 (0.74 to 0.85) | 0.90 |
219 ng/mL | 0.86 (0.71 to 1.00) | 0.81 (0.76 to 0.86) | ||
228 ng/mL | 0.81 (0.62 to 0.95) | 0.84 (0.79 to 0.89) | ||
238 ng/mL | 0.76 (0.57 to 0.95) | 0.87 (0.82 to 0.91) | ||
IL-6 | 16.8 pg/mL | 0.81 (0.62 to 0.95) | 0.60 (0.53 to 0.67) | 0.78 |
19.3 pg/mL | 0.76 (0.57 to 0.90) | 0.65 (0.58 to 0.73) | ||
20.0 pg/mL | 0.71 (0.52 to 0.90) | 0.66 (0.60 to 0.73) | ||
24.8 pg/mL | 0.67 (0.48 to 0.86) | 0.75 (0.66 to 0.79) | ||
Hyaluronan | 94.5 ng/mL | 0.81 (0.62 to 0.95) | 0.47 (0.41 to 0.54) | 0.62 |
101.5 ng/mL | 0.71 (0.52 to 0.90) | 0.51 (0.44 to 0.58) | ||
108.0 ng/mL | 0.67 (0.48 to 0.86) | 0.52 (0.45 to 0.58) | ||
115.0 ng/mL | 0.62 (0.43 to 0.81) | 0.53 (0.46 to 0.53) | ||
CA125 | 3.85 U/mL | 0.81 (0.62 to 0.95) | 0.23 (0.17 to 0.29) | 0.51 |
4.45 U/mL | 0.71 (0.52 to 0.90) | 0.30 (0.23 to 0.37) | ||
6.55 U/mL | 0.62 (0.43 to 0.81) | 0.50 (0.43 to 0.57) | ||
7.05 U/mL | 0.52 (0.33 to 0.71) | 0.53 (0.46 to 0.59) |
Table 6 Test performance of effluent matrix metalloproteinase-2 cut-off levels to predict the encapsulating peritoneal sclerosis in peritoneal dialysis patients
Cut-off level | Sensitivity (95%CI) | Specificity (95%CI) | AUC |
458.5 | 1.00 (1.00 to 1.00) | 0.96 (0.94 to 0.98) | 0.99 |
609.5 | 0.88 (0.63 to 1.00) | 0.99 (0.98 to 1.00) | |
863.5 | 0.63 (0.25 to 0.88) | 1.00 (0.99 to 1.00) |
- Citation: Hirahara I, Kusano E, Morishita Y, Inoue M, Akimoto T, Saito O, Muto S, Nagata D. Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis. World J Nephrol 2016; 5(2): 204-212
- URL: https://www.wjgnet.com/2220-6124/full/v5/i2/204.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i2.204